Human papillomavirus and cervical cancer

  title={Human papillomavirus and cervical cancer},
  author={Mark Schiffman and Philip E. Castle and Jose Jeronimo and Ana Cecilia Rodriguez and Sholom Wacholder},
  journal={The Lancet},

Figures and Tables from this paper

Human papillomavirus and cervical cancer
  • K. Okunade
  • Medicine, Biology
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
  • 2019
HPV testing in the secondary prevention of cervical cancer is clinically valuable in triaging low-grade cytological abnormalities and is also more sensitive than cytology as a primary screening.
Human Papillomavirus and Cervical Cancer
  • Saliha Sağnıç
  • Medicine, Biology
    Cervical Cancer - A Global Public Health Treatise [Working Title]
  • 2021
HPV plays a major role in the development of cervical cancer, but histological types have different relationships with HPV genotypes, and HPV vaccination provides a direct benefit to both men and women by providing safe protection against cancers that may result from persistent HPV infection.
[Human papillomavirus infection. Pathology and molecular pathology].
The Ständige Impfkommission, the German standing committee on immunizations, has recommended the prophylactic use of vaccines against the two most frequent HR-HPV genotypes, HPV-16 and HPV-18, in women age 12-17 years before first sexual intercourse.
Human papillomaviruses as therapeutic targets in human cancer.
  • K. Hellner, K. Münger
  • Biology, Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2011
It has been estimated that there will be no measurable decline of HPV-associated cervical cancers before 2040, and therapeutic efforts to combat high-risk HPV- associated disease remain of critical importance.
Role of HPV16 E1 in cervical carcinogenesis
  • F. Baedyananda
  • Biology
    Frontiers in Cellular and Infection Microbiology
  • 2022
A possible mechanism by which E1 drives cell proliferation and oncogenesis will be discussed, and the emerging role of HPV E1 in cervical carcinogenesis is emphasized.
Human papillomavirus infection and its role in the pathogenesis of anal cancer
Studies are currently in progress to determine whether treatment of anal HSIL reduces the risk of cancer among HIV-infected men and women, and to define the molecular events associated with progression from HSIL to cancer.
HPV and Cervical Cancer
The very high negative predictive value of HPV testing speaks in favor of its use in screening of cervical cancer to reduce the mortality related to this neoplasia particularly in developing countries.
Human Papillomavirus in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era
Men and women with human immunodeficiency virus (HIV) infection are at high risk of HPV-related malignancies and should be screened for cervical HSIL and cancer, and HIV-infected men and women should be considered for anal screening programs.
Prevention of Complications from Human Papillomavirus Infection in the HIV-Infected Individual
Ongoing work to optimize screening for both cervical and anal HSIL to prevent cancer at these sites, as well as increasing uptake of prophylactic HPV vaccines, are currently the best options to decrease HPV-related complications in PLWH.


Molecular biology of human papillomavirus infection and cervical cancer.
High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia, and the pattern of viral gene expression in low- grade cervical lesions resembles that seen in productive warts caused by other HPV types.
The epidemiology of human papillomavirus infections.
  • J. Baseman, L. Koutsky
  • Biology, Medicine
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
  • 2005
Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.
This chapter suggests promising areas of future epidemiologic research on human papillomavirus (HPV) and anogenital cancer, organized around our understanding of cervical carcinogenesis. The major
A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.
Although virtually all HPV infections clear within 2 years, the remaining infections have a high potential for persistence and, by implication, progression to precancer and cancer.
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.
The lack of evident severe abnormalities associated with HPV18 and related HPV types might have implications for screening for poorly detected glandular and alpha7-related lesions, as well as the potential of the full range of anogenital HPV genotypes to induce cytopathic effects.